1. Home
  2. IMA vs VERI Comparison

IMA vs VERI Comparison

Compare IMA & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IMA

ImageneBio Inc.

N/A

Current Price

$4.11

Market Cap

66.3M

Sector

Health Care

ML Signal

N/A

Logo Veritone Inc.

VERI

Veritone Inc.

N/A

Current Price

$0.48

Market Cap

57.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
IMA
VERI
Founded
2019
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
66.3M
57.7M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
IMA
VERI
Price
$4.11
$0.48
Analyst Decision
Buy
Buy
Analyst Count
4
3
Target Price
★ $18.00
$4.50
AVG Volume (30 Days)
12.1K
★ 3.8M
Earning Date
11-20-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
$800,000.00
★ $92,637,000.00
Revenue This Year
N/A
$11.05
Revenue Next Year
N/A
$33.37
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.88
$0.51
52 Week High
$8.84
$6.13

Technical Indicators

Market Signals
Indicator
IMA
VERI
Relative Strength Index (RSI) 42.78 33.63
Support Level $3.91 N/A
Resistance Level $6.13 $0.67
Average True Range (ATR) 0.22 0.06
MACD 0.04 0.01
Stochastic Oscillator 39.48 18.09

Price Performance

Historical Comparison
IMA
VERI

About IMA ImageneBio Inc.

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

About VERI Veritone Inc.

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has presence in the United States, the United Kingdom, France, Australia, Israel, and India.

Share on Social Networks: